Which stent for STEMI?

According to two trials presented at the ACC national meeting it's too close to call between bare-metal and drug-eluting stents. Larger studies are needed, but it looks as though there may be a trade off between a substantial risk of revascularization due to in-stent restenosis (bare metal) and a smaller risk of cardiovascular catastrophe due to stent thrombosis (drug eluting). Will Prasugrel tip the balance in favor of DES?